This is the authors' abstract. We don't add key points for this paper.
In a recent article, Bas and collaborators compared different serological methods to detect chlamydial antibodies in patients withChlamydia trachomatis infections and healthy blood donors (1). Using the Labsystems enzyme immunoassay (EIA) forC. pneumoniae, no cross-reaction between C. trachomatis and C. pneumoniae was found. However, Gnarpe and collaborators recently showed cross-reactions betweenC. trachomatis and C. pneumoniae, when the Labsystems EIA for C. pneumoniae was used on sera containing high titers of C. trachomatis antibodies documented by the microimmunofluorescence (MIF) test (2). A broader cross-reactivity between the different chlamydial species was suspected. The Labsystems EIA test has previously been shown to have high sensitivity and specificity in the diagnosis of acute infections caused by C. pneumoniae during an epidemic of C. pneumoniae (3).
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Strålin et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: